Urogen Pharma Ltd. (URGN)
NASDAQ · Healthcare
Urogen Pharma Ltd. Gross Profit 2016–2025
Urogen Pharma Ltd. annual/quarterly gross profit history and growth rate from 2016 to 2026. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.
- Urogen Pharma Ltd. gross profit for the quarter ending March 31, 2026 was 46.8 M, a 161.21% increase year-over-year.
- Urogen Pharma Ltd. gross profit for the twelve months ending March 31, 2026 was 109.6 M, a 40.70% increase year-over-year.
- Urogen Pharma Ltd. annual gross profit for 2025 was 97.3 M, a 19.41% increase from 2024.
- Urogen Pharma Ltd. annual gross profit for 2024 was 81.5 M, a 11.13% increase from 2023.
- Urogen Pharma Ltd. annual gross profit for 2023 was 73.4 M, a 29.36% increase from 2022.
- Urogen Pharma Ltd. annual gross profit for 2022 was 56.7 M.
Gross Profit
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Urogen Pharma Ltd. Gross Profit — FAQ
Urogen Pharma Ltd. (URGN) gross profit over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
What is Urogen Pharma Ltd.'s gross profit?
Urogen Pharma Ltd. (URGN) reported gross profit of $97M for fiscal 2025.
Where can I see URGN's gross profit history?
The chart and table above show Urogen Pharma Ltd.'s gross profit by year and by quarter, including the growth rate.